<DOC>
	<DOCNO>NCT01211301</DOCNO>
	<brief_summary>The purpose study compare effectiveness Medifast 5 &amp; 1 Plan food-based , reduced-energy diet plan . The study conduct 52 week , include 26-week weight-loss phase 26-week weight-maintenance phase . 120 participant enrol , 60 randomize Medifast 5 &amp; 1 Plan 60 randomized food-based , reduced-energy diet plan . Multiple measure perform baseline , 26 week , 52 week , include anthropometry , body composition , blood pressure , blood assay , appetite sensation .</brief_summary>
	<brief_title>Medifast 5 &amp; 1 Plan</brief_title>
	<detailed_description />
	<mesh_term>Body Weight</mesh_term>
	<mesh_term>Overweight</mesh_term>
	<mesh_term>Weight Loss</mesh_term>
	<mesh_term>Nutrition Disorders</mesh_term>
	<criteria>BMI 3550 kg/m2 Interested weight loss Computer internet access Any race ethnicity Fasting glucose &lt; 126 mg/dL screen Participation weightreduction program , weightloss diet , special diet within previous 3 month . Weight loss gain &gt; 5 % body weight past 6 month reason except postpartum weight loss . Currently take medication suppresses stimulate appetite . History prior surgical procedure weight control liposuction . Current smoker quit smoke less 6 month prior . Any major disease , include : Active cancer cancer require treatment past 2 year ( except nonmelanoma skin cancer ) . Active chronic infection , include selfreported HIV positivity active tuberculosis . Active cardiovascular disease event include hospitalization therapeutic procedure treatment heart disease ( e.g. , coronary artery bypass , percutaneous transluminal coronary angioplasty ) past 6 month ; New York Heart Association Functional Class &gt; 2 respect congestive heart failure ; stroke transient ischemic attack past 6 month . Uncontrolled hypertension : systolic blood pressure &gt; 160 mm Hg diastolic blood pressure &gt; 95 mm Hg treatment . Gastrointestinal disease , include selfreported chronic hepatitis cirrhosis , episode alcoholic hepatitis alcoholic pancreatitis within past year , inflammatory bowel disease require treatment past year , recent significant abdominal surgery ( e.g. , gastrectomy ) . Active kidney disease . Lung disease : chronic obstructive airway disease require use oxygen . Diagnosed diabetes ( type 1 2 ) , fast hyperglycemia ( blood glucose &gt; 126 mg/dL ) , use antidiabetic medication . Uncompensated uncontrolled psychiatric disease ( schizophrenia bipolar disorder ) , opinion investigator , would impede conduct trial completion procedure . A score Brief Symptom Inventory ( BSI ) ( Derogatis &amp; Melisaratos , 1983 ) exceed 90th percentile . History current eating disorder , Eating Attitudes Test ( EAT 40 ) score &gt; 30 . Active food allergy , particularly wheat , gluten , soy nut . Conditions behavior likely effect conduct trial : unable unwilling give inform consent ; unable communicate pertinent clinic staff ; another household member participant staff member trial ; unwilling accept treatment assignment randomization ; current anticipated participation another intervention research project would interfere intervention offer trial ; likely move away participate clinic trial complete ; unable walk 0.25 mile 10 minute . Currently take antidepressant , steroid , thyroid medication , unless dosage stable . No regular source health care . Any active use illegal illicit drug history illegal illicit drug utilization within past year Excessive alcohol intake , either acute chronic define one following : 1 ) average consumption 3 alcohol contain beverage daily ; 2 ) consumption 7 alcoholic beverage within 24hr period past 12 month ; 3 ) evidence available clinic staff . Willing limit alcohol intake zero Pregnancy childbearing : currently pregnant less 3 month post partum ; currently nurse within 6 week complete nursing ; pregnancy anticipate study ; unwilling report possible confirm pregnancy promptly course trial ; unwilling take adequate contraceptive measure potentially fertile . Any condition , opinion investigator , would adversely affect conduct trial .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>obesity</keyword>
	<keyword>overweight</keyword>
	<keyword>weight loss</keyword>
	<keyword>randomize control trial</keyword>
	<keyword>Medifast</keyword>
</DOC>